Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly
University of Washington
P2/3
BB
(64)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
T-Cell/Histiocyte Rich Large B Cell Lymphoma
Ruijin Hospital
P2/3
BB
(64)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Acute Lymphoblastic Leukemia
University of Birmingham
P2/3
BB
(64)
Inno-206
Acute Leukemia
SWOG Cancer Research Network
P2/3
BB
(64)
Inno-206
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P2/3
BB
(64)
Inno-206
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern University
P2/3
BB
(64)
Inno-206
Hematologic Diseases
Hellenic Society of Hematology
P2/3
BB
(64)
Inno-206
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Northwestern University
P2/3
BB
(64)
ip-001
Metastasis From Malignant Tumor Of Colon
Immunophotonics, Inc.
P2/3
BB
(64)
Ipilimumab
Gliosarcoma
University College, London
P2/3
BB
(64)
Ivospemin
Pancreatic Ductal Adenocarcinoma
Panbela Therapeutics, Inc.
P2/3
BB
(64)
Naxtarubicin
Acute Myeloid Leukemia
Moleculin Biotech, Inc.
P2/3
BB
(64)
Nivolumab
Urinary Bladder Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Nivolumab
Gliosarcoma
Andrew P. Groves
P2/3
BB
(64)
Olaparib
Castration-Resistant Prostate Carcinoma
AstraZeneca
P2/3
BB
(64)
Plavix
Cirrhosis, Liver
M.D. Anderson Cancer Center
P2/3
BB
(64)
PREDNISONE TABLETS
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
National Cancer Institute (NCI)
P2/3
BB
(64)
PREDNISONE TABLETS
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Northwestern University
P2/3
BB
(64)
PREDNISONE TABLETS
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
Northwestern University
P2/3
BB
(64)
Pumitamig
Colorectal Cancer
Bristol-Myers Squibb
P2/3
BB
(64)
RANITIDINE
Breast Cancer
Ohio State University Comprehensive Cancer Center
P2/3
BB
(64)
Rapamycin
Recurrent Childhood Acute Myeloid Leukemia
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2/3
BB
(64)
Relatlimab
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Relatlimab
Muscle Invasive Ureter Urothelial Carcinoma
National Cancer Institute (NCI)
P2/3
BB
(64)
Semaglutide
Heart Failure
University Medical Centre Ljubljana
P2/3
BB
(64)
Showing 251 to 275 of 1,482 assets
Previous
Page 11 of 60
Next